Recursion Pharmaceuticals, Inc. (RXRX)
3.38
+0.05
(+1.50%)
USD |
NASDAQ |
Sep 02, 16:00
3.38
0.00 (0.00%)
After-Hours: 05:36
Recursion Pharmaceuticals Cash and Short Term Investments (Quarterly) : 551.07M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 551.07M |
| March 31, 2026 | 659.98M |
| December 31, 2025 | 747.89M |
| September 30, 2025 | 662.97M |
| June 30, 2025 | 528.22M |
| March 31, 2025 | 503.53M |
| December 31, 2024 | 597.40M |
| September 30, 2024 | 429.20M |
| June 30, 2024 | 476.12M |
| March 31, 2024 | 299.52M |
| December 31, 2023 | 394.80M |
| September 30, 2023 | 389.58M |
| Date | Value |
|---|---|
| June 30, 2023 | 409.20M |
| March 31, 2023 | 474.46M |
| December 31, 2022 | 551.19M |
| September 30, 2022 | 456.74M |
| June 30, 2022 | 517.34M |
| March 31, 2022 | 592.63M |
| December 31, 2021 | 518.11M |
| September 30, 2021 | 589.14M |
| June 30, 2021 | 642.97M |
| March 31, 2021 | 219.13M |
| December 31, 2020 | 267.17M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Twist Bioscience Corp. | 166.84M |
| Absci Corp. | 201.14M |
| Novavax, Inc. | 719.34M |
| Editas Medicine, Inc. | 211.64M |
| Halozyme Therapeutics, Inc. | 231.00M |